BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
BioMarin Pharmaceutical Inc. (BMRN) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 20, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More BMRN filings
- 4
Filed Nov 19, 2026
- 144
Filed Nov 18, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 2, 2026
- 8-K
Filed Oct 6, 2026
- 4
Filed Oct 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.